A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers (Q34434145)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers |
scientific article |
Statements
1 reference
A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers (English)
1 reference
F Joel Leong
1 reference
Rong Zhao
1 reference
Shuqi Zeng
1 reference
Baldur Magnusson
1 reference
Thierry T Diagana
1 reference
Peter Pertel
1 reference
18 August 2014
1 reference
1 reference
Identifiers
1 reference